The Association of High Body Mass Index with the Risk of Placenta Previa: A Systematic Review
Keywords:
Placenta Previa, Body Mass Index, Obesity, Overweight, Risk Factor, Systematic Review, Cesarean SectionAbstract
Introduction: Placenta previa is a significant cause of maternal and neonatal morbidity, primarily due to antepartum hemorrhage. Concurrently, the global prevalence of maternal obesity is rising, a condition associated with numerous adverse pregnancy outcomes. The direct relationship between high maternal Body Mass Index (BMI) and the risk of developing placenta previa remains contentious, with conflicting evidence from observational studies. This systematic review aims to critically appraise and synthesize the available evidence to clarify this association.
Methods: A systematic search of PubMed, Google Scholar, Semanthic Scholar, Springer, Wiley Online Library was conducted to identify all relevant cohort and case-control studies published in English. Studies were included if they investigated the association between pre-pregnancy or early-pregnancy BMI (categorized as overweight or obese) and the incidence of placenta previa in pregnant women, compared to those with a normal BMI. Two independent reviewers performed study selection, data extraction, and quality assessment using the Newcastle-Ottawa Scale (NOS). A formal risk of bias assessment was also conducted using the Cochrane Risk of Bias in Non-randomized Studies - of Interventions (ROBINS-I) tool. A narrative synthesis of the findings was performed.
Results: Seventeen studies, comprising large-scale retrospective cohorts and case-control studies, met the inclusion criteria. The majority of high-quality studies, particularly those with robust adjustment for confounding variables, found no statistically significant direct association between high maternal BMI and the risk of placenta previa. Unadjusted analyses in some studies suggested a weak association, but this effect was consistently attenuated and lost statistical significance after controlling for key confounders, most notably a history of prior cesarean delivery. Analysis of secondary outcomes revealed that high BMI is strongly associated with an increased risk for primary cesarean delivery, gestational diabetes, and preeclampsia.
Discussion: The weight of the evidence suggests that high maternal BMI is not an independent, direct risk factor for placenta previa. The association observed in unadjusted analyses is likely an artifact of confounding. A plausible indirect causal pathway is proposed: high BMI increases the risk of a primary cesarean delivery in a woman's first pregnancy, and the resultant uterine scarring is a powerful, established risk factor for placenta previa in a subsequent pregnancy. The pathophysiological mechanisms of obesity, such as systemic inflammation, appear to drive metabolic and hypertensive complications rather than influencing the specific site of placental implantation.
Conclusion: The link between high maternal BMI and placenta previa is indirect, mediated primarily through the increased rate of cesarean delivery. Clinical counseling for women with high BMI should emphasize the well-established risks of gestational diabetes, hypertensive disorders, and the increased likelihood of a primary cesarean section, along with the long-term reproductive consequences of that surgery, including a future risk of placenta previa.
References
Adere, A., Mulu, A. and Temesgen, F. (2020). Neonatal and Maternal Complications of Placenta Praevia and Its Risk Factors in Tikur Anbessa Specialized and Gandhi Memorial Hospitals: Unmatched Case-Control Study. Journal of Pregnancy, 2020, 5630296.
Aman, A., Misbah, D., Syed, M., Shinwari, L., Nawaz, R. and Farooq, M.U. (2020). Prevalence of Placenta Previa and its Risk Factors in Pregnant Women Attending Tertiary Care Hospital. Medical Forum, 31(11), pp.44-47.
Ananth, C.V., Keyes, K.M., and Wapner, R.J. (2015). The risk factors associated with placenta previa: An umbrella review. Placenta, 117, pp.21-27.
Ananth, C.V., Savitz, D.A. and Luther, E.R. (2009). Maternal body mass index and placental abruption: a retrospective cohort study. Human Reproduction, 24(2), pp.438-444.
Arrowsmith, S., Wray, S. and Quenby, S. (2011). Maternal obesity and labour complications. Best Practice & Research Clinical Obstetrics & Gynaecology, 25(5), pp.607-618.
Bartsch, E., Medcalf, K.E., Park, A.L. and Ray, J.G. (2016). Clinical risk factors for placenta accreta spectrum: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 215(2), pp.160-171.
Chen, Y., et al. (2022). Analysis of influencing factors and perinatal outcomes of placenta previa in first-time pregnant women. Frontiers in Surgery, 9, 862655.
Cresswell, J.A., Ronsmans, C., Calvert, C. and Filippi, V. (2013). Prevalence of placenta praevia by world region: a systematic review and meta-analysis. Tropical Medicine & International Health, 18(6), pp.712-724.
Dalbye, R., et al. (2017). Maternal body mass index and risk of postpartum hemorrhage: a cohort study. BMC Pregnancy and Childbirth, 17(1), p.32.
Dashe, J.S., McIntire, D.D., Ramus, R.M., Santos-Ramos, R. and Twickler, D.M. (2002). Persistence of placenta previa according to gestational age at ultrasound detection. Obstetrics & Gynecology, 99(5 Pt 1), pp.692-697.
Fleming, M., Spence, D., Currie, G. and Semple, K. (2020). Cohort study of high maternal body mass index and the risk of adverse pregnancy and delivery outcomes in Scotland. BMJ Open, 10(2), e026168.
Gebre, E.G., et al. (2024). Determinants of placenta previa among pregnant women delivered in public hospitals in Wolaita Zone, Southern Ethiopia: a facility-based unmatched case-control study. medRxiv.
Huda, S.S., Brodie, L.E. and Sattar, N. (2010). Obesity in pregnancy: pathophysiology and consequences. Best Practice & Research Clinical Obstetrics & Gynaecology, 24(5), pp.547-561.
Jauniaux, E. and Jurkovic, D. (2012). Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta, 33(4), pp.244-251.
Jauniaux, E., Alfirevic, Z., Bhide, A.G., Belfort, M.A., Burton, G.J., Collins, S.L., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., Silver, R. and Sentilhes, L. (2019). Placenta Praevia and Placenta Accreta: Diagnosis and Management. Green-top Guideline No. 27a. BJOG: An International Journal of Obstetrics & Gynaecology, 126(1), pp.e1-e48.
Jenabi, E. and Nazari, A. (2024). Obesity and risk of placenta accreta spectrum: A meta-analysis. Medicine, 103(41), e39434.
Kayem, G., et al. (2024). Risk factors for placenta accreta spectrum in women with at least one previous cesarean delivery and a placenta previa or low-lying: the PACCRETA prospective study. Scientific Reports, 14(1), 5897.
Khazaei, S., et al. (2022). The relationship between history of caesarean deliveries with placenta previa: A meta-analysis. International Journal of Health Sciences, 6(S2), pp.5550-5559.
Knight, M. (2007). Antenatal and postnatal thromboembolism. In: Saving Mothers' Lives: Reviewing Maternal Deaths to Make Motherhood Safer - 2003-2005. London: CEMACH.
Lavery, J.P. (1990). Placenta previa. Clinical Obstetrics and Gynecology, 33(3), pp.414-421.
Lisonkova, S., et al. (2017). The impact of pre-pregnancy body mass index and gestational weight gain on placental abruption risk: a systematic review and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 124(6), pp.880-890.
Liu, B., et al. (2024). Factors and outcomes for placental anomalies: An umbrella review of systematic reviews and meta-analyses. Journal of Translational Medicine, 22(1), p.123.
Maiti, S., Kanrar, P., Karmakar, C., Chakrabarti, S. and Mandal, A. (2014). Risk factors of placenta previa among rural Indian women. Journal of Evolution of Medical and Dental Sciences, 3(65), pp.14163-14168.
March of Dimes. (2021). Being overweight during pregnancy. Available at: https://www.marchofdimes.org/find-support/topics/pregnancy/being-overweight-during-pregnancy
Mayo Clinic. (2024). Placenta previa. Available at: https://www.mayoclinic.org/diseases-conditions/placenta-previa/symptoms-causes/syc-20352768
Merck Manuals. (2023). Placenta Previa. Professional Version. Available at: https://www.merckmanuals.com/professional/gynecology-and-obstetrics/antenatal-complications/placenta-previa
Musa, M.G., et al. (2023). Maternal obesity and placental pathology in correlation with adverse pregnancy outcome. Romanian Journal of Morphology and Embryology, 63(1), pp.99-104.
NHS. (2023). Obesity and pregnancy. Available at: https://www.nhs.uk/pregnancy/related-conditions/existing-health-conditions/overweight/
Roberts, K.A., Riley, S.C., Reynolds, R.M., Barr, S., Evans, M., Statham, A., Hor, K., Jabbour, H.N., Norman, J.E. and Denison, F.C. (2011). Placental structure and inflammation in pregnancies complicated by maternal obesity. Placenta, 32(3), pp.247-254.
Salim, R., et al. (2022). Prevalence of placenta previa and its associated risk factors: a case-control study. Revista Brasileira de Ginecologia e Obstetrícia, 44(08), pp.750-755.
Sekiguchi, A., et al. (2011). Risk factors for placental abruption and placenta previa: a case-cohort study. Archives of Gynecology and Obstetrics, 283(3), pp.505-510.
Silver, R.M. (2015). Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstetrics & Gynecology, 126(3), pp.654-668.
Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for assessing the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), pp.603-605.
Sterne, J.A.C., Hernán, M.A., Reeves, B.C., Savović, J., Berkman, N.D., Viswanathan, M., Henry, D., Altman, D.G., Ansari, M.T., Boutron, I., Carpenter, J.R., Chan, A-W., Churchill, R., Deeks, J.J., Hróbjartsson, A., Kirkham, J., Jüni, P., Loke, Y.K., Pigott, T.D., Ramsay, C.R., Regidor, D., Rothstein, H.R., Sandhu, L., Santaguida, P.L., Schünemann, H.J., Shea, B., Shrier, I., Tugwell, P., Turner, L., Valentine, J.C., Waddington, H., Waters, E., Wells, G.A., Whiting, P.F. and Higgins, J.P.T. (2016). ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. The BMJ, 355, i4919.
Tuzović, L., Djelmis, J. and Ilijić, M. (2003). Obstetric risk factors associated with placenta previa development: case-control study. Croatian Medical Journal, 44(6), pp.728-733.
Vieira, L.A., et al. (2021). The relation between maternal obesity and placenta accreta spectrum: A multinational database study. Acta Obstetricia et Gynecologica Scandinavica, 100(S1), pp.50-57.
Voigt, M., et al. (2025). Risk factors and feto-maternal outcome of placenta previa: a ten-year analysis. Journal of Perinatal Medicine.
Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M. and Tugwell, P. (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
World Health Organization. (2021). Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Yang, J., Ye, S., Xuan, B., Liu, Z. and Fan, D. (2025). Gestational overweight decreased risk of antepartum hemorrhage in pregnant women with complete placenta previa: a retrospective study. PeerJ, 13, e19091.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ivandra Septiadi Tama Putra, Penri Fransiskus Manulang, Jansen Renaldi, Lidya Aprilia Sari (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
